Cancer, Covid-19, Vaccine
Showing 1 - 25 of >10,000
Efficacy and Safety of COVID-19 Vaccine in Cancer Patients
Active, not recruiting
- COVID-19 Infection
- Malignant Solid Neoplasm
- Biospecimen Collection
- Electronic Health Record Review
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 6, 2023
Health Behavior, Colorectal Cancer, Influenza Trial in New Orleans (Financial incentive for colorectal cancer screening,
Recruiting
- Health Behavior
- +6 more
- Financial incentive for colorectal cancer screening
- +2 more
-
New Orleans, LouisianaTulane University School of Medicine
Nov 13, 2023
Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic
Not yet recruiting
- Chronic Lymphocytic Leukemia
- COVID-19 Infection
- Biospecimen Collection
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 3, 2023
Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients
Active, not recruiting
- Cancer
- Covid19
- COVID-19 vaccine
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 9, 2022
Covid19, Cancer, Malignancy Trial in Tucson (SARS-COV2 Pfizer Vaccine)
Completed
- Covid19
- +3 more
- SARS-COV2 Pfizer Vaccine
-
Tucson, ArizonaUniversity of Arizona
May 19, 2022
SARS-CoV-2 mRNA-1273 Vaccine in Select Subsets of Oncology
Active, not recruiting
- Covid19
- Cancer
- Blood Sample
-
Rochester, New YorkUniversity of Rochester
Sep 6, 2022
COVID-19 Immunogenicity ofThird Dose of mRNA-1273 Vaccine Among
Active, not recruiting
- Covid19
- SARS-CoV2 Infection
- mRNA-1273
-
Tampa, FloridaMoffitt Cancer Center
Jun 20, 2022
SARS-CoV-2 Vaccination on Cancer Patients Infected With
Recruiting
- COVID-19 Infection
- COVID-19 Vaccine
- no intervention
-
Beijing, Beijing, ChinaSanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
Mar 7, 2023
Host Immune Response to Novel RNA COVID-19 Vaccination
Recruiting
- COVID-19 Vaccine
- Cancer
- COVID-19 Vaccine
-
San Antonio, TexasMays Cancer Center, UT Health San Antonio
Apr 22, 2022
To Assess Immunogenicity of Coronavirus Disease 2019 Vaccine in
Recruiting
- Breast Cancer
- +2 more
- COVID-19 Vaccine
-
Kansas City, KansasThe University of Kansas Cancer Center, Westwood Campus
Mar 31, 2022
Coronavirus Disease 2019 Vaccination in Cancer Patients
Recruiting
- Malignancies Multiple
- COVID-19 vaccine hesitancy and acceptance survey
-
Hershey, PennsylvaniaPenn State Cancer Institute
Feb 28, 2022
COVID-19, Cancer Trial in Ratchathewi (CoronaVac vaccine)
Completed
- COVID-19
- Cancer
- CoronaVac vaccine
-
Ratchathewi, Bangkok, ThailandNational Cancer Institute
Apr 9, 2022
Multiple Myeloma, AL Amyloidosis, Chronic Lymphocytic Leukemia Trial in Detroit (A single "booster" dose of the Moderna mRNA
Recruiting
- Multiple Myeloma
- +2 more
- A single "booster" dose of the Moderna mRNA COVID-19 vaccine
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Apr 12, 2022
Cancer Trial in Amsterdam, Groningen, Rotterdam (mRNA-1273 SARS-CoV-2 vaccine from Moderna)
Active, not recruiting
- Cancer
- mRNA-1273 SARS-CoV-2 vaccine from Moderna
-
Amsterdam, Netherlands
- +2 more
Mar 1, 2022
Covid19, Cancer Trial in Istanbul (COVID-19 antibody test)
Completed
- Covid19
- Cancer
- COVID-19 antibody test
-
Istanbul, Fatih, Turkey
- +4 more
Aug 1, 2021
COVID-19 Infection Trial in Duarte (Placebo Administration, Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1)
Recruiting
- COVID-19 Infection
- Placebo Administration
- Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Dec 15, 2021
COVID-19 Vaccine in Immunotherapy and Non-IO Treated Cancer
Completed
- COVID-19
- Cancer
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Oct 1, 2021
COVID-19 Infection, Hematopoietic and Lymphoid System Tumor, Leukemia Trial in Duarte (COVID-19 Vaccine, Diagnostic Laboratory
Recruiting
- COVID-19 Infection
- +4 more
- COVID-19 Vaccine
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 2, 2021
Patients With Cancer, Vaccine Reaction, COVID-19 Trial in Beijing (Coronavirus vaccination)
Recruiting
- Patients With Cancer
- +2 more
- Coronavirus vaccination
-
Beijing, China302 Hospital
Apr 11, 2022
mRNA Covid-19 Vaccines on Cancer Patients:Observational Study.
Recruiting
- Cancer
- +2 more
- Serum collection, adverse events collection
-
Cremona, Lombardia, ItalyUO Oncologia, ASST di Cremona
Jul 22, 2021
Third Dose of SARS-CoV-2 Vaccine inCohort of Cancer Patients on
Recruiting
- Sars-CoV-2 Infection
- Three doses of BNT162b2 (observational)
- Two doses of Coronavac and one dose BNT162b2 (observational)
-
Santiago, ChileRed de Salud UC Christus
Feb 1, 2022
COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection Trial (Novavax COVID-19 vaccine (2023-2024 formula XBB containing),
Not yet recruiting
- COVID-19
- +4 more
- Novavax COVID-19 vaccine (2023-2024 formula XBB containing)
- Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)
- (no location specified)
Sep 29, 2023
Coronavirus, Coronavirus Infection, Coronavirus as the Cause of Diseases Classified Elsewhere Trial in Los Angeles, Bryan,
Active, not recruiting
- Coronavirus
- +2 more
- BCG Vaccine
- Placebo Vaccine
-
Los Angeles, California
- +5 more
Oct 18, 2022
Cancer Trial in Belgium (Blood sampling)
Recruiting
- Cancer
- Blood sampling
-
Edegem, Antwerp, Belgium
- +7 more
Aug 31, 2021
BNT162b2 Messenger Ribonucleic Acid Covid-19 Vaccine in Cancer
Recruiting
- Neoplasms
- Cancer, Treatment-Related
- BNT162b2 mRNA Covid-19 Vaccine
-
Genova, ItalyE.O. Ospedali Galliera
Jun 18, 2021